VTA-100
/ Vita Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 19, 2023
First preclinical results for VTA-100 reported by Vita Therapeutics
(Bioworld)
- "At the recent International Society for Stem Cell Research meeting, Vita Therapeutics Inc. presented the first preclinical results on VTA-100, a cell therapy consisting of induced pluripotent stem cell (iPSC)-derived satellite cells, for the treatment of limb-girdle muscular dystrophy 2A/R1."
Preclinical • CNS Disorders • Muscular Dystrophy
1 to 1
Of
1
Go to page
1